Variant · Snv
SPAG17 NM_206996.4(SPAG17):c.6107T>A (p.Leu2036Gln)
CI-VAR-00338839Explore in graph →p.Leu2036GlnNM_206996.4:c.6107T>AClinVar 3060565 rs61729968
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 3060565 | Benign | no assertion criteria provided | 0 | SPAG17-related disorder; Sarcoma; Ovarian serous cystadenocarcinoma; Uterine carcinosarcoma; Melanoma; Malignant tumor of esophagus; Acute myeloid leukemia; Lung cancer | germline | 2 | Oct 18, 2019 | clinvar |